Cover Image

Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differences

Saved in:
Bibliographic Details
Main Authors: Kriegsmann, Mark (Author) , Endris, Volker (Author) , Pfarr, Nicole (Author) , Stenzinger, Albrecht (Author) , Schneeweiss, Andreas (Author) , Sinn, Peter (Author) , Weichert, Wilko (Author)
Format: Article (Journal)
Language:English
Published: 2014
In: OncoTarget
Year: 2014, Volume: 5, Issue: 20, Pages: 9952-9965
ISSN:1949-2553
DOI:10.18632/oncotarget.2481
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.18632/oncotarget.2481
Get full text
Author Notes:Mark Kriegsmann, Volker Endris, Thomas Wolf, Nicole Pfarr, Albrecht Stenzinger, Sibylle Loibl, Carsten Denkert, Andreas Schneeweiss, Jan Budczies, Peter Sinn and Wilko Weichert

MARC

LEADER 00000caa a2200000 c 4500
001 1525274155
003 DE-627
005 20220812151553.0
007 cr uuu---uuuuu
008 160209s2014 xx |||||o 00| ||eng c
024 7 |a 10.18632/oncotarget.2481  |2 doi 
035 |a (DE-627)1525274155 
035 |a (DE-576)455274150 
035 |a (DE-599)BSZ455274150 
035 |a (OCoLC)1340897664 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kriegsmann, Mark  |d 1987-  |e VerfasserIn  |0 (DE-588)103740324X  |0 (DE-627)755668782  |0 (DE-576)39141870X  |4 aut 
245 1 0 |a Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differences  |c Mark Kriegsmann, Volker Endris, Thomas Wolf, Nicole Pfarr, Albrecht Stenzinger, Sibylle Loibl, Carsten Denkert, Andreas Schneeweiss, Jan Budczies, Peter Sinn and Wilko Weichert 
264 1 |c 2014 
300 |a 14 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 09.02.2016 
700 1 |a Endris, Volker  |e VerfasserIn  |0 (DE-588)1063753686  |0 (DE-627)812590961  |0 (DE-576)422898198  |4 aut 
700 1 |a Pfarr, Nicole  |e VerfasserIn  |0 (DE-588)1063753309  |0 (DE-627)812590414  |0 (DE-576)422897701  |4 aut 
700 1 |a Stenzinger, Albrecht  |e VerfasserIn  |0 (DE-588)139606106  |0 (DE-627)703395238  |0 (DE-576)312432755  |4 aut 
700 1 |a Schneeweiss, Andreas  |d 1961-  |e VerfasserIn  |0 (DE-588)109972554  |0 (DE-627)632849630  |0 (DE-576)327251859  |4 aut 
700 1 |a Sinn, Peter  |d 1957-  |e VerfasserIn  |0 (DE-588)1022590944  |0 (DE-627)717004783  |0 (DE-576)365646342  |4 aut 
700 1 |a Weichert, Wilko  |d 1970-2023  |e VerfasserIn  |0 (DE-588)123509106  |0 (DE-627)56134650X  |0 (DE-576)293740461  |4 aut 
773 0 8 |i Enthalten in  |t OncoTarget  |d [Erscheinungsort nicht ermittelbar] : Impact Journals LLC, 2010  |g 5(2014), 20, Seite 9952-9965  |h Online-Ressource  |w (DE-627)63035975X  |w (DE-600)2560162-3  |w (DE-576)325343764  |x 1949-2553  |7 nnas  |a Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differences 
773 1 8 |g volume:5  |g year:2014  |g number:20  |g pages:9952-9965  |g extent:14  |a Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differences 
856 4 0 |u http://dx.doi.org/10.18632/oncotarget.2481  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20160209 
993 |a Article 
994 |a 2014 
998 |g 123509106  |a Weichert, Wilko  |m 123509106:Weichert, Wilko  |d 910000  |d 912000  |e 910000PW123509106  |e 912000PW123509106  |k 0/910000/  |k 1/910000/912000/  |p 11  |y j 
998 |g 1022590944  |a Sinn, Peter  |m 1022590944:Sinn, Peter  |d 910000  |d 912000  |e 910000PS1022590944  |e 912000PS1022590944  |k 0/910000/  |k 1/910000/912000/  |p 10 
998 |g 109972554  |a Schneeweiss, Andreas  |m 109972554:Schneeweiss, Andreas  |d 910000  |d 912000  |e 910000PS109972554  |e 912000PS109972554  |k 0/910000/  |k 1/910000/912000/  |p 8 
998 |g 139606106  |a Stenzinger, Albrecht  |m 139606106:Stenzinger, Albrecht  |d 910000  |d 912000  |e 910000PS139606106  |e 912000PS139606106  |k 0/910000/  |k 1/910000/912000/  |p 5 
998 |g 1063753309  |a Pfarr, Nicole  |m 1063753309:Pfarr, Nicole  |d 910000  |d 912000  |e 910000PP1063753309  |e 912000PP1063753309  |k 0/910000/  |k 1/910000/912000/  |p 4 
998 |g 1063753686  |a Endris, Volker  |m 1063753686:Endris, Volker  |d 910000  |d 912000  |e 910000PE1063753686  |e 912000PE1063753686  |k 0/910000/  |k 1/910000/912000/  |p 2 
998 |g 103740324X  |a Kriegsmann, Mark  |m 103740324X:Kriegsmann, Mark  |d 910000  |d 912000  |e 910000PK103740324X  |e 912000PK103740324X  |k 0/910000/  |k 1/910000/912000/  |p 1  |x j 
999 |a KXP-PPN1525274155  |e 2897663685 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"name":{"displayForm":["Mark Kriegsmann, Volker Endris, Thomas Wolf, Nicole Pfarr, Albrecht Stenzinger, Sibylle Loibl, Carsten Denkert, Andreas Schneeweiss, Jan Budczies, Peter Sinn and Wilko Weichert"]},"note":["Gesehen am 09.02.2016"],"person":[{"family":"Kriegsmann","role":"aut","display":"Kriegsmann, Mark","given":"Mark"},{"role":"aut","family":"Endris","given":"Volker","display":"Endris, Volker"},{"family":"Pfarr","role":"aut","display":"Pfarr, Nicole","given":"Nicole"},{"display":"Stenzinger, Albrecht","given":"Albrecht","role":"aut","family":"Stenzinger"},{"display":"Schneeweiss, Andreas","given":"Andreas","role":"aut","family":"Schneeweiss"},{"display":"Sinn, Peter","given":"Peter","role":"aut","family":"Sinn"},{"family":"Weichert","role":"aut","display":"Weichert, Wilko","given":"Wilko"}],"recId":"1525274155","id":{"eki":["1525274155"],"doi":["10.18632/oncotarget.2481"]},"physDesc":[{"extent":"14 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title_sort":"Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differences","title":"Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differences"}],"origin":[{"dateIssuedDisp":"2014","dateIssuedKey":"2014"}],"relHost":[{"origin":[{"dateIssuedDisp":"2010-","publisher":"Impact Journals LLC","publisherPlace":"[Erscheinungsort nicht ermittelbar]","dateIssuedKey":"2010"}],"id":{"eki":["63035975X"],"issn":["1949-2553"],"zdb":["2560162-3"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"OncoTarget","title":"OncoTarget","subtitle":"open access impact journal"}],"recId":"63035975X","disp":"Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differencesOncoTarget","type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.2010,Mai -"],"note":["Gesehen am 16.08.2018"],"part":{"pages":"9952-9965","extent":"14","issue":"20","text":"5(2014), 20, Seite 9952-9965","volume":"5","year":"2014"},"language":["eng"]}]} 
SRT |a KRIEGSMANNMUTATIONAL2014 

Similar Items